期刊文献+

血清抗心磷脂抗体与系统性红斑狼疮肾小球微血栓形成之间的关系 被引量:1

Research of Relationship of Anticardilipin antibodies and Glomerular Capillary Thrombosis in Patients with Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的探讨系统性红斑狼疮(SLE)患者血清抗心磷脂抗体(ACA)与其他致病抗体、临床表现、疾病活动性、生化指标及肾小球毛细血管血栓形成之间的关系。方法采用 ELISA 法检测36例 SLE 患者和30例健康对照者血清 ACA,并分析 SLE 患者的临床表现、实验室指标及肾小球毛细血管病理改变与 ACA 的关系。结果 36例 SLE 患者中,ACA 阳性率显著高于健康对照组(P<0.001)。肾活检病理结果显示,ACA 阳性组肾小球毛细血管血栓的发生率高达59%,而阴性组仅为 14%,两组肾小球血栓发生率比较差异有显著性(X^2=3.96,P<0.05)。结论 SLE 患者血清 ACA 可能参与 SLE 肾小球微血栓形成、关节免疫性炎症反应及其他系统炎症损害的机理。 Objective To study the relationship between anticardilipin antibodies (ACA) and other pathogenic antibodies, clinical manifestation,biochemical indicators and glomerular capillary thrombosis in patients with systemic lupus erythematosus (SLE). Methods The enzyme-linked immunosorbent assay (ELISA) was used to measure the ACA in serum of 36 SLE patients and 30 healthy contors. We analysised the clinical menifestations, laboratory indexes and glomerular capillary pathological changes in patients of SLE. Results The positive ACA of the 36 SLE patients was significantly higher than those of healthy controls (P 〈 0. 001 ). Renal biopsy pathology, the incidence rate of glomerular capillary thrombosis was 59% in ACA positive ,while 14% in ACA negative. There was significant difference in two sets( x^2 = 3.96, P 〈 0. 005 ). Conclusion ACA in SLE patients may take part in glomerular capillary thrombosis, articulation immunity inf- amation reaction and other immunity mechanisms.
出处 《血栓与止血学》 2006年第1期9-12,共4页 Chinese Journal of Thrombosis and Hemostasis
关键词 抗心磷脂抗体 系统性红斑狼疮 血栓形成 血清 Anticardilipin antibody Systemic lupus erythematosus
  • 相关文献

参考文献8

  • 1[3]LOVE P,SANTORO A.Antiphospholipid antibodies:anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE)and non-SLE discorders:prevalence and clinical significance [J].Ann Intern Med,1990,112(9) :682-698.
  • 2刘玉荣,尹国才,邵理成,余秀齐.血清抗—SSA与类风湿因子的相关性分析[J].海军总医院学报,1995,8(4):251-252. 被引量:1
  • 3[5]HAMMOND A,RUDGE AC,LOIZON S,et al.Reduced number of complement receptor type 1 on erthrocytes are associated with increase levels of anticardiolipin antibodies.Finding in patients with systemic lupus erythematosus and the antiphospholipid syndrome[J].Arthritis Rheum,1989,32 (3) :259-264.
  • 4[6]GOMEZ-PUERTA JA,MARTIN H.Long-term follow-up in 128 patients with primary antiphospholipid syndrome:dothey develop lupus[J]? Medicine,2005,84 (4):225-230.
  • 5钟清,唐萸香,谯林,刘渝梅.狼疮性肾炎患者抗心磷脂抗体的测定及其临床意义[J].重庆医科大学学报,2003,28(1):11-13. 被引量:2
  • 6[8]LIPPE Von,FELLA A.Antibodies against platelet glycoproteins antiphospholipid antibodies in antoimmune thrombocytopenia[J].Eur J Haematol,1998,60:283-288.
  • 7[9]SCHORER A,WICKHAM N,WATSON K.Lupus anticoagulant induces a selective defect in thrombin-mediated endothelial prosacyclin release and platelet aggregation [J].Br J Haematil,1989,71(3) :399-407.
  • 8[10]FRAMPTON G,HICKS J,CAMERON JS.Significance of antiphospholipid antibodies in patients with lupus nephritis [J].Kindney Int,1991,39 (3):1125-1231.

二级参考文献8

  • 1[1]Love P, Santoro A. Antiphospholipid antibodies: anticardi olipin and the lupus anticoagulant in systemic lupus erythematosus(SLE) and non- SLE disorders: prevalence and clinical sig-nificance [J]. Ann Intern Med, 1990; 112(9) :682 - 698.
  • 2[2]Harmnond A, Rudge AC, Loizou S, et al. Reduced number of complement receptor type 1 on erthrocytes are associated with increased levels of anticardiolipin antibodies. Findings in patients with systemic lupus erythematosus and the antiphospholipid syndrome [ J ]. Arthritis Rheum, 1989; 32 ( 3 ): 259 -264.
  • 3[3]Von scheven E, Athreya B, Rose C, et al. Clinical charac teristics of antiphospholipid antibody syndrome in children [J]. JPediatr, 1996; 129(3) :339 - 345.
  • 4[4]Ricchieri GL, Pizzoluto G, Fabbri M, et al. Gerebral andvien thrombosis , transient protein S deficiency , and anticardiolipin antibodies [J]. Am J Hematol, 1996;512( 1 ) :69 - 70.
  • 5[5]Schorer A,Wickharn N,Watson K. Lupus anticoagulant induces a selective defect in thrombin mediated endothelial prostacyclin release and platelet aggregation [J ]. Br J Haematol,1989;71(3) :399 - 407.
  • 6[6]Frampton G, Hicks J, Cameron JS. Significance of antiphospholipid antibodies in patients with lupus nephritis [J ]. Kidney Iht, 1991 ;39(3): 1125 - 1231.
  • 7[7]Leaker B, Mcgregor A, Grittiths M, et al. Insidious loss of renal function in patients with anticardiolipin antibodies and absence of overt nephritis [ J ]. Br J Rheumatol, 1991; 30 ( 6 ): 422 - 425.
  • 8[8]Ishii Y, Nagasawa K, Mayumi T, et al. Clinical importance of anticardiolipin antibodies in systemic lupus erythematosus [J]. Ann Rheum Dis, 1990;49(6) :387 - 390.

共引文献1

同被引文献4

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部